Achillion Gets a Boost from J&J
Bill Mathews

Achillion Pharmaceuticals (ACHN) discovers, develops, and commercializes small molecule drug therapies for infectious diseases...

Tickers: ACHN | JNJ
Enterprise: A Blue Chip among MLPs
Peter Staas

Enterprise Products Partners LP (EPD) offers exposure an impressive array of other upside drivers that should play out over the...

Tickers: EPD
Nelson Peltz Eyes Procter & Gamble
Charles Carlson

Procter & Gamble (PG) is one of my oldest holdings. I first bought these shares roughly 25 years ago and have added to them via...

Tickers: PG
Prudent Picks in Gold
Jason Clark

Jason Clark is a leading value investor and contributing editor to The Prudent Speculator. Here, he looks at two gold stocks th...

Tickers: ABX | AUY
Comcast: A "Split" Choice
Neil Macneale III

Each month, Neil Macneale selects one stock to add to his model portfolio at 2-for-1 Stock Split Newsletter. Each new buy recom...

Tickers: CMCSA
Diamond Offshore: High Value at a Bargain Price
Jim Powell

Companies that drill for energy are slow to benefit from rising oil and gas prices. That's because most producers won't start l...

Tickers: DO
Marine Harvest: Fat Dividend from Healthy Seafood
Mark Skousen

Based in Norway, Marine Harvest (MHG) is one of the world's largest seafood companies, and the single largest producer of Atlan...

Tickers: MHG
Bristol-Myers Squibb: Value Play?
Joe Duarte

It's time to stop thinking of Bristol-Myers Squibb (BMY) as a growth darling and start thinking about it as a value stock, asse...

Tickers: BMY
Cliffs Natural and Domestic Steel
Nate Pile

There is no doubt that our infrastructure is long overdue for some attention, and this, in turn, will require a lot of steel (w...

Tickers: CLF
Incyte: Best in Class?
John McCamant

Incyte (INCY) and their partner Lilly announced that the European Commission has granted marketing authorisation for Olumiant (...

Tickers: INCY
 

Expert Investing and Trading Advice

If you’re an independent investor, trader or financial advisor in search of relevant, reliable and timely financial advice, you’ve come to the right place! Before you pave your own path to profits, you need to arm yourself with state-of-the-art tools, a powerful skill set and an absolute understanding of the markets. Guided by the principle that “knowledge is power,” for more than three decades MoneyShow has been carefully handpicking the resources that perceptive investors and traders need to succeed.

 

MoneyShow.com has over 1,500 contributors who are among the most respected and trusted names in the financial field. These experts bring daily market insights, stock picks and trading tips, and actionable advice regarding the day’s hottest topics to our MoneyShow.com readers.

Investment Education to Help You Succeed

MoneyShow makes pertinent articles available on its website to help you become a more informed, knowledgeable and successful investor. Our readers get exclusive access to ideas, analyses and long- and short-term investment strategies from the world’s leading market experts — expert authors with proven track records of successful investing.

Subscribe to E-Newsletters

Whether you’re an independent investor or trader or a seasoned pro looking for sophisticated strategies, you’ll find useful advice — from stocks, bonds, mutual funds and ETFs to currencies, futures and global investing. Our articles offer you the actionable advice you need to achieve your financial goals.